Imaging & Radiology

Sells FDA-cleared AI triage and quantification software for CT and X-ray through its aiOS platform, now built on the CARE foundation model. More than 30 510(k) clearances since 2018.

Bunkerhill Health develops FDA-cleared AI algorithms that find cardiovascular and bone disease on imaging and ECGs ordered for other reasons. Hospitals run them through its Carebricks platform.

Develops AI software that quantifies coronary inflammation and plaque from coronary CT angiography to predict cardiac risk. University of Oxford spinout with a U.S. office in Stamford, Connecticut.

Builds the Op.n surgical platform, which combines 2D and 3D imaging, navigation and robotic guidance for spine and orthopedic procedures, and is open to third party implants and applications. Enovis agreed to acquire the company in September 2026.

Builds PlaqueIQ, FDA-cleared software that quantifies plaque composition from coronary CT angiography, and a BioIntegrated FFR-CT product under FDA review.

HistoSonics makes the Edison histotripsy system, which uses focused ultrasound to destroy liver tumors without incisions, heat or radiation.

King's College London spinout selling HyperSnap, a hyperspectral imaging system that shows tissue oxygenation and composition during surgery. Cleared under K250268 in June 2025 with product code SFE.

Makes Skylight, a system that projects medical images onto the patient during procedures so surgeons do not use a headset or look away at a monitor. Aimed at spine surgery, pain management and interventional radiology.

Makes a compact automated scanner that captures a 3D ultrasound volume of the breast in about a minute, with machine learning applied to flag abnormal masses.

Building real time 3D ultrasound systems meant to replace 2D imaging for procedures such as vascular access and central line placement.

Builds robotic microscopes and vision guided scanning systems for cancer diagnostics and digital pathology.

Handheld imaging device using frequency domain near infrared spectroscopy to indicate within a week of starting treatment whether a breast cancer therapy is working.

Builds optical coherence tomography systems with AI detection for assessing surgical margins during cancer surgery. Listed on the TSX Venture Exchange as PINK.

Pulsenmore makes a smartphone cradle that lets pregnant women perform ultrasound scans at home for remote reading by clinicians. It is listed on the Tel Aviv Stock Exchange.

Makes a very small forward looking camera on a catheter for imaging inside blood vessels during neurovascular procedures.